Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sorrento Therapeutics, Inc. - Common Stock (NQ:SRNE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sorrento Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Market Briefing For Monday, Dec. 20
If we're going to have a so-called Santa Claus rally, it may start from washouts Monday or Tuesday. 
Via Talk Markets
Market Briefing For Thursday, Dec. 9
Via Talk Markets
Market Briefing For Wednesday, Dec. 8
The surge extended and this time brought more small-caps along with what was a broad advance that is partially attributable to 'hopium' regarding reduced fears about COVID-Omicron. 
Via Talk Markets
Market Briefing For Tuesday, Dec. 7
Multiple challenges are not yet 'definitive' crises, but evolving situations and as such the market will experience alternating swings until it works through them. 
Via Talk Markets
2 Big Stock Bets That Are Insiders Are Buying Now
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not... 
Via FinancialNewsMedia
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! We're starting off another busy week with a look at the biggest pre-market stock movers for Monday! 
Via InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
Gainers CF Acquisition Corp. VI (NASDAQ: CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble. Digital... 
Via Benzinga
Market Briefing For Tuesday, Nov. 30
With the Fed-head trying to damper optimism in the morning, a higher high is likely deferred, but if we subsequently get one it might be with VIX below 15, again. 
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Moonshot Biotechs with 10x Potential
This strategy identified LGVN stock a month ago, and now its price has skyrocketed. Here are two more biotechs that could do the same. 
Via InvestorPlace
Market Briefing For Wednesday, Nov. 17 - The EV Edition
Raising expectations is exactly what Wall Street needed, to deny any sort of 'double-top' possibility for S&P. Perhaps that's why Goldman Sachs chose today to increase their target to 5100. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Global COVID-19 Therapeutics Market Size Now Expected To Exceed $25 Billion In 2030
Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result in the... 
Via FinancialNewsMedia
Topics Death
Exposures COVID-19 Death
Market Briefing For Tuesday, Nov. 9
Optimizing portfolio strategies in this market, is fairly straight-forward, even if it doesn't fit catch-phrase descriptions of overbought vs oversold or valuations in an extended or undervalued way.... 
Via Talk Markets
Market Briefing For Thursday, Nov. 4
Offsetting influences are factors which influence the superficially neutral policies of the Fed. By maintaining 'emergency' near-zero rates after the 'emergency', it's soothing to markets, but actually... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Thursday, Oct. 28
Downward revisions of growth by the Atlanta Fed 'reverse' prior expectations, although it's particularly interesting since 'heavier' economic conditions tend to keep the Fed more 'at-bay'; though that... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Thursday, Oct. 21
Margin 'compression' is a traditional concern about stock prices, especially in big-cap issues, which depend on ongoing operations more than technology, as is often priced based on forthcoming rather... 
Via Talk Markets
Market Briefing For Wednesday, Oct.13
A complex battle has been outlined on both sides of S&P 4400. So, having forecast the rebounds to that area, we expected no defining structure, quickly answering questions about whether there was more... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Briefing For Wednesday, Oct. 6
'Raising the stakes' reasonably describes the backdrop surrounding stocks as well as longer range market prospects, fiscal conditions, geopolitical (most obvious China-Taiwan) threats, Oil prices,... 
Via Talk Markets
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
Exposures COVID-19
Market Briefing For Tuesday, Oct. 5
A bear trend developed under cover of distribution for months during which there was little upside potential, and plenty of downside risk. Bounces, periodically will occur, and we may or may not... 
Via Talk Markets
Dear SRNE Stock Fans, Here’s the Latest Patent News to Watch
Despite some relatively bullish news that came out yesterday, investors in vaccine stocks such as SRNE stock are in sell mode today. 
Via InvestorPlace
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Market Briefing For Wednesday, Sept. 29
Negativity in the market accelerates as the 'obviousness' of primary challenges tends to be inflated (no pun), so as to explain a 'correction process' that persists adhering to the pattern outlined... 
Via Talk Markets
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
Via FinancialNewsMedia
Exposures COVID-19
Skip the Bullsh*t! CEO Speak Reveals 2 Reddit Stock Gems
Are Redditors Being Fooled By Corporate Showmanship? “If you can’t dazzle them with brilliance, baffle them with bullsh*t.” — W.C. Fields I’ve long suspected that overly dazzling CEOs make for poor... 
Via InvestorPlace
Market Briefing For Thursday, Sept. 23
Decoupling 'tapering' from rate 'hikes' was the preferred path presumed by probably everybody; and that's what we got. GDP forecasts were lowered by the Fed, which infers lack of 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
Via FinancialNewsMedia
Exposures COVID-19
Market Briefing For Wednesday, Sept. 22
True-to-form - market behavior gave no mixed signals on Tuesday. It was up with a bounce; then dipped, bounced, and faded as it went on-hold ahead of the FOMC meeting. 
Via Talk Markets
3 COVID Stocks That Might Double Soon
Here are three healthcare stocks as nominees for a quick double in 2021. 
Via The Motley Fool
Market Briefing For Wednesday, Sept. 15
In light of today's inflation print; you have a negative real yield for mainstream debt; and that's tying into the distress in China (Evergrande again) showing a possible disruption that could cascade... 
Via Talk Markets
Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients
Via FinancialNewsMedia
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS